These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32063212)

  • 41. Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study).
    Kim SG; Kim S; Hwang YH; Kim K; Oh JE; Chung W; Oh KH; Kim HJ; Ahn C;
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S117-22. PubMed ID: 18552239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peritoneal Dialysis.
    Andreoli MCC; Totoli C
    Rev Assoc Med Bras (1992); 2020 Jan; 66Suppl 1(Suppl 1):s37-s44. PubMed ID: 31939534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incremental peritoneal dialysis: Clinical outcomes and residual kidney function preservation.
    Borràs Sans M; Chacón Camacho A; Cerdá Vilaplana C; Usón Nuño A; Fernández E
    Nefrologia; 2016; 36(3):299-303. PubMed ID: 27137104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. International comparison of peritoneal dialysis prescriptions from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).
    Wang AY; Zhao J; Bieber B; Kanjanabuch T; Wilkie M; Marshall MR; Kawanishi H; Perl J; Davies S;
    Perit Dial Int; 2020 May; 40(3):310-319. PubMed ID: 32063209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical effects of combined therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S126-9. PubMed ID: 17556290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.
    Li T; Wilcox CS; Lipkowitz MS; Gordon-Cappitelli J; Dragoi S
    Am J Nephrol; 2019; 50(6):411-421. PubMed ID: 31630148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.
    Wong B; Ravani P; Oliver MJ; Holroyd-Leduc J; Venturato L; Garg AX; Quinn RR
    Am J Kidney Dis; 2018 Mar; 71(3):344-351. PubMed ID: 29174322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Incremental peritoneal dialysis - conclusions].
    Viglino G
    G Ital Nefrol; 2012; 29(4):392-3. PubMed ID: 22843151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
    Qi H; Xu C; Yan H; Ma J
    Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of automated peritoneal dialysis on the decrease in residual renal function.
    Hufnagel G; Michel C; Queffeulou G; Skhiri H; Damieri H; Mignon F
    Nephrol Dial Transplant; 1999 May; 14(5):1224-8. PubMed ID: 10344365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sodium toxicity in peritoneal dialysis: mechanisms and "solutions".
    Borrelli S; De Nicola L; Minutolo R; Perna A; Provenzano M; Argentino G; Cabiddu G; Russo R; La Milia V; De Stefano T; Conte G; Garofalo C;
    J Nephrol; 2020 Feb; 33(1):59-68. PubMed ID: 31734929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changing Landscape for Peritoneal Dialysis: Optimizing Utilization.
    Schreiber MJ
    Semin Dial; 2017 Mar; 30(2):149-157. PubMed ID: 28144977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations Between Peritoneal Glucose Exposure, Glucose Degradation Product Exposure, and Peritoneal Membrane Transport Characteristics in Peritoneal Dialysis Patients: Secondary Analysis of the
    Nataatmadja MS; Johnson DW; Pascoe EM; Darssan D; Hawley CM; Cho Y;
    Perit Dial Int; 2018; 38(5):349-355. PubMed ID: 30087174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of residual renal function in peritoneal dialysis patients.
    Diaz-Buxo JA; White SA; Himmele R
    Adv Perit Dial; 2013; 29():19-24. PubMed ID: 24344485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.
    Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GF; Wiggins KJ
    Nephrol Dial Transplant; 2013 Jul; 28(7):1899-907. PubMed ID: 23493329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of peritoneal permeability and residual renal function on PD prescription.
    Harty J; Gokal R
    Perit Dial Int; 1996; 16 Suppl 1():S147-52. PubMed ID: 8728182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2005 Guidelines on targets for solute and fluid removal in adults being treated with chronic peritoneal dialysis: 2019 Update of the literature and revision of recommendations.
    Boudville N; de Moraes TP
    Perit Dial Int; 2020 May; 40(3):254-260. PubMed ID: 32048566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recommended clinical practices for maximizing peritoneal dialysis clearances.
    Blake P; Burkart JM; Churchill DN; Daugirdas J; Depner T; Hamburger RJ; Hull AR; Korbet SM; Moran J; Nolph KD
    Perit Dial Int; 1996; 16(5):448-56. PubMed ID: 8914175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adequacy in dialysis: intermittent versus continuous therapies.
    Misra M; Nolph KD
    Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.